Showing results (511-520 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|January 6, 2025
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancerReha-Baris Incesu, Felix Preisser, Florian Nohe, et al.
Prostate Cancer and Prostatic Diseases|December 5, 2024
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancerMichiel Vlaming, Margreet G E M Ausems, Lambertus A L M Kiemeney, et al.
Prostate Cancer and Prostatic Diseases|December 2, 2024
Salvage irreversible electroporation for locally recurrent prostate cancer after definitive radiotherapy: a systematic reviewMehmet Yilmaz, Mustafa Karaaslan, Mehmet Emin Şirin, et al.
Prostate Cancer and Prostatic Diseases|December 20, 2024
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysisYali Meng, Jianjiang Liu, Bin Shen, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE studyUrszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experienceSunao Shoji, Jun Naruse, Sena Ohno, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2024
Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategiesJoseph Moryousef, Wilhelmina Duivenvoorden, Darryl Leong, et al.
Prostate Cancer and Prostatic Diseases|November 9, 2025
Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patientsL Bianchi, A Mottaran, B Bortolani, et al.
Prostate Cancer and Prostatic Diseases|November 18, 2025
The role of the human microbiome in prostate cancer: a systematic review from diagnosis to treatmentAlfredo Distante, Davide Garino, Clara Cerrato, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2025
Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort studyRosalba Rosato, Stefano De Luca, Andrea Zitella, et al.
Pageof 199